Photo from wikipedia
Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for pr... Click to show full abstract
Brain butyrylcholinesterase (BChE) is an attractive target for drugs designed for the treatment of Alzheimer’s disease (AD) in its advanced stages. It also potentially represents a biomarker for pr...
Keywords:
development potent;
selective inhibitors;
potent reversible;
inhibitors butyrylcholinesterase;
reversible selective;
butyrylcholinesterase fluorescent
Journal Title: Journal of Enzyme Inhibition and Medicinal Chemistry
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Enzyme Inhibition and Medicinal Chemistry
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!